-transparent.png){kind=logo}
Ioversol 320, a new nonionic iodinated contrast medium, was injected intravenously into 24 healthy male volunteers using saline as a control. Physical examination, vital signs, electrocardiogram, biochemical and hematological data were recorded before and at intervals after injection. No significant changes were observed. Seventeen volunteers reported no side effects; six volunteers had mild transitory symptoms considered to be related to the contrast medium. The authors conclude that broader clinical trials can be safely conducted to determine safety and tolerability of ioversol.
Related Publications
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
July 2007,
European journal of clinical pharmacology,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
December 2012,
Arzneimittel-Forschung,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
May 1996,
The Journal of antimicrobial chemotherapy,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
June 2005,
Journal of clinical pharmacology,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
October 2004,
Biopharmaceutics & drug disposition,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
February 2019,
Clinical therapeutics,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
September 2008,
Naunyn-Schmiedeberg's archives of pharmacology,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
October 2014,
Antimicrobial agents and chemotherapy,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
June 1990,
Antimicrobial agents and chemotherapy,
R A Wilkins, and
J R Whittington, and
G S Brigden, and
A Lahiri, and
M E Heber, and
L O Hughes
January 2021,
Clinical pharmacology in drug development,
